|
業務類別
|
Biotechnology |
|
業務概覽
|
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly ownedSwedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Thecompany manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets. |
| 公司地址
| 21 Firstfield Road, Gaithersburg, MD, USA, 20878 |
| 電話號碼
| +1 240 268-2000 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.novavax.com |
| 員工數量
| 749 |
| Mr. John C. Jacobs |
Director, President and Chief Executive Officer |
美元 752.50K |
26/02/2026 |
| Mr. James P. Kelly |
Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer |
美元 545.90K |
26/02/2026 |
| Ms. Elaine O'Hara |
Executive Vice President and Chief Strategy Officer |
美元 535.60K |
29/04/2025 |
| Mr. Mark J. Casey |
Executive Vice President, Chief Legal Officer and Corporate Secretary |
美元 558.25K |
29/04/2025 |
| Dr. Ruxandra Draghia-Akli |
Executive Vice President and Head of Research and Development |
-- |
29/04/2025 |
|
|
| Ms. Margaret G. McGlynn |
Chairman of the Board |
26/02/2026 |
| Dr. Gregg H. Alton, J.D. |
Independent Director |
26/02/2026 |
| Mr. David M. Mott |
Independent Director |
26/02/2026 |
| Mr. John C. Jacobs |
Director, President and Chief Executive Officer |
26/02/2026 |
| Dr. John W. Shiver, PhD |
Independent Director |
26/02/2026 |
| Mr. Charles W. Newton |
Independent Director |
26/02/2026 |
| Dr. Richard H. Douglas, PhD |
Independent Director |
26/02/2026 |
| Ms. Rachel K. King |
Independent Director |
26/02/2026 |
| Mr. Richard J. Rodgers |
Independent Director |
26/02/2026 |
|
|
|
|
